The future of digital health part 4: Convergence of AI and analytics for healthcare payers

Part 4

This post is the fourth and final of our Digital Health series, featuring healthcare visionary and thought leader Andy Dé. In this series, Dé has been discussing how COVID-19 has triggered remarkable digital transformation and uncovers five long-term innovation implications that providers, healthcare leaders, and payers need to consider.

To catch up on the previous three posts, navigate to the following links:

Innovation implication #1: Advanced analytics for vaccine administration

Innovation implication #2: Digital patient engagement and virtual healthcare delivery

Innovation implications #3: Artificial intelligence and machine learning for operations, revenue cycle and supply chain innovation and #4: Medical robotics

Then, read on to explore today’s topic: Artificial Intelligence and analytics.


Innovation implication #5: Convergence of AI and analytics for healthcare payers

Healthcare payers are experiencing tremendous, pandemic-driven cost pressures as well as unprecedented changes to their reimbursement mixes (thanks to the explosive growth of telehealth and similar services). To stay successful, I predict payers will extensively leverage advanced descriptive, spatial, predictive and prescriptive analytics driven by a convergence of analytics and artificial intelligence comprising machine learning, natural language processing, and deep learning.

In this post, I’ll follow the strategy framework laid out in the below graphic and detail each high value area of potential investment in advanced analytics.

1. Innovate with new products and services for new segments of customers

The COVID-19 pandemic and the resulting economic catastrophe has caused millions of Americans to be laid off or furloughed – usually losing employer provided health coverage as a result.

Simultaneously, 32.8 million Americans have been infected by COVID-19 as of today and many will suffer long-term physical effects of the virus. COVID-19 has become a “pre-existing condition” for these afflicted patients.

Deploying advanced analytics and AI will help payers identify the changing needs of their customers and respond to their evolving needs with newer products and services that will enable new revenue streams to compensate for lost revenue.

2. Minimize customer churn through value-added programs

Advanced predictive and prescriptive analytics have helped large healthcare payers to better understand their customer behavior, address dissonance with their products and services and deploy value-added programs to minimize customer churn. These steps have helped protect millions in revenue, which would otherwise have been lost.

3. Improve process efficiencies

Healthcare payers are also challenged with several administrative processes which are manual, inefficient, onerous and can negatively impact employee morale (e.g., claims administration and management).

I foresee industry leaders deploying best practices like analytics- and AI-enabled Lean Six-Sigma for value stream mapping to stratify current processes in terms of value-add vs. non-value-add process steps from the customer’s perspective. This will enable them to eliminate non-value-add processes or steps, enhancing process efficiency, customer satisfaction and employee productivity – and saving millions in costs.

4. Minimize fraud, waste and abuse for millions in cost savings

Fraudulent claims filed on behalf of patients by unscrupulous physicians, providers and predatory pharmacies is a significant challenge, which costs healthcare payers billions in leakage every year.

Deploying advanced machine learning and natural language processing algorithms with analytic automation will help payers to proactively flag and detect fraud, identify waste and abuse pertaining to claims administration, management and reimbursement – and save them millions in leakage and cost savings each year.

This concludes our series on the future of digital health. Thank you for following along!

I hope you’ve learned key insights and gained actionable takeaways that can be incorporated into your strategic plans and preparation pathways. To discuss any of these implications further, reach out to start the conversation. Let’s innovate together!

Andy Dé

Andy Dé is the Chief Marketing Officer. Andy joined MedeAnalytics in March 2021 bringing more than 20 years of enterprise software product marketing, product management and industry strategy experience. In his role, Andy oversees the company’s go-to-market (GTM) strategy and marketing. He is passionate about healthcare innovation and is recognized as an industry thought leader in healthcare.

Get our take on industry trends

Providers: Are you ready to be audited?

February 15, 2022

By Donna Kennedy In 2020, regular audits conducted by CMS and other payers were paused or significantly reduced as the…

Read on...

From Insights to Action – The Digital Transformation of Healthcare in the Post-Pandemic “New Normal”

February 10, 2022

In November, MedeAnalytics hosted the 2021 Impact Summit, an engaging and educational event held annually and designed exclusively for our…

Read on...
From Insights to Action – The Digital Transformation of Healthcare in the Post-Pandemic “New Normal”

2022 Rx: Your new, post-pandemic prescription for success

January 11, 2022

By Dave Schweppe, Chief Analytics Officer, MedeAnalytics Despite the common use of the term “post-COVID,” most leaders across the healthcare…

Read on...
Combating the opioid epidemic photo

Combating the opioid epidemic in North America with Nobel Prize winning research

October 12, 2021

American Researchers Dr. David Julius and Dr. Ardem Patapoutian from California were awarded the Nobel Prize in medicine for their path breaking work on the development of non-opioid painkillers, showing immense promise for combating the epidemic.

Read on...